Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Inovio presents updated results from HVTN 098 phase I clinical study of PENNVAX-GP

Oct. 26, 2018

Reservoir SMACdown could fight latent HIV

Oct. 23, 2018

Merck Sharp & Dohme enrolling patients in phase I study of MK-8583 for HIV-1

Oct. 22, 2018

MacroGenics studies MGD-014 in patients with HIV infection on suppressive ART

Oct. 22, 2018

Aelix and Gilead collaborate to study HTI T-cell vaccine with vesatolimod in HIV

Oct. 19, 2018

ST Pharm discovers new HIV integrase inhibitors

Oct. 19, 2018

GS-6207 shows long-acting nonclinical pharmacokinetic profile

Oct. 11, 2018

Vedolizumab may help eliminate HIV infection by attenuating lymphoid aggregates

Oct. 9, 2018

Two-fisted punch prevents HIV rebound

Oct. 8, 2018

NK problems facilitate bnAbs in HIV

Oct. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...